US Patent Issued to LISATA THERAPEUTICS on July 8 for "Pharmaceutical compositions comprising novel cyclic peptides" (American, Finnish Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,653, issued on July 8, was assigned to LISATA THERAPEUTICS INC..

"Pharmaceutical compositions comprising novel cyclic peptides" was invented by Harri Jarvelainen (Tampere, Finland) and Erkki Ruoslahti (Rancho Santa Fe, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are novel cyclic peptides, their synthetic process, compositions, properties including stability and pharmacokinetic profiles, and applications for treating solid tumor cancers."

The patent was filed on Jan. 15, 2025, under Application No. 19/023,048.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Par...